There were no differences in age, body mass index (BMI), cardiovascular risk factors, and current medications (β-adrenoceptor blockers, calcium channel blockers, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) among the control, CAD and AMI groups (all P > 0.05). This evidence concerns the gene ACE and coronary artery disorder.